Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Harnessing the Power of UV Light for Virus Protection

The world is currently facing a probable epidemic related to the coronavirus. According to the Centers for Disease Control and Prevention (CDC), coronavirus (COVID-19) spreads just as other viruses do from person-to-person, mostly through respiratory droplets that occur when an infected individual sneezes or coughs. The world is on hyper-alert for ways to mitigate its spread, and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The world is currently facing a probable epidemic related to the coronavirus. According to the Centers for Disease Control and Prevention (CDC), coronavirus (COVID-19) spreads just as other viruses do from person-to-person, mostly through respiratory droplets that occur when an infected individual sneezes or coughs.

The world is on hyper-alert for ways to mitigate its spread, and one proven way to destroy viruses is via ultraviolet (UV) light, which may be a good option for a variety of scenarios.

UV Light Is an Effective Tool to Stop the Spread of Viruses

Much research has been completed on destroying viruses and germs. A certain spectrum of UV light—UVC—has been proven to kill airborne viruses, and it does so in a manner that presents no risk to humans. UVC refers to ultraviolet light with wavelengths between 200 – 280 nanometers (nm). A study conducted by a group of scientists found that UVC had the ability to kill flu viruses when placed in germ-sensitive places like hospitals, airports and schools.

While the coronavirus is different than the flu, it’s similar in nature. UVC is stealthy enough to destroy viruses.

The CDC also sponsored a study about the impact of UVC by using it in hospital patient rooms. The conclusions drawn from the researchers’ data confirmed that UVC-emitting devices could decrease the “bioburden of important pathogens in real-world settings.”

Introducing UV Light into HVAC Airflow and Ventilation Systems

Each day, you and your family venture out into the public domain and have a high probability of encountering germs and viruses. You probably already practice good hygiene to reduce these chances, such as thorough handwashing or use of hand sanitizer, but the threat remains.

Being able to harness the power of UVC light can make all the difference in stopping the spread and multiplication of these germs and viruses.

By introducing UV light into your airflow and ventilation systems, you’ll be better prepared to protect yourself from them.

Leveraging UV Light into Your Spaces with Field Controls

Integrating UV light into your home doesn’t require scientific expertise or a huge investment.

The Field Controls UV-Aire UV-16 unit has been designed to emit strong UVC band light through your heating or air conditioning system, sterilizing and reducing airborne microorganisms. It works to neutralize the organism’s DNA so that it can no longer replicate. As new indoor air circulates through your system, it’s being passed through the UV light, effectively treating it.

Field Controls completed multiple independent lab tests to verify its effect on viruses and germs, finding that it reduced test bacteria by 90% within 30 minutes. While the technology is highly advanced, it’s extremely simple to install. They require minimal maintenance, and you don’t need extensive training to use the products in your home.

Experience Added Protection with the UV-Aire UV-16

Doing all you can to safeguard from the coronavirus and other airborne pathogens is vital, and you can effectively do so with the UV-Aire UV-16.

Learn more about how it works and how it can deliver a healthier space today.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Physician burnout stems not just from workload but from loss of meaningful voice in healthcare organizations. Dr. Krishna Vedala discusses how primary care is mismanaged as a procedural business, how AI should free physicians from administrative work rather than replace them, and why physicians may need collective representation to restore trust between clinicians and administrators.

  • 01Physicians increasingly lack meaningful participation in organizational decisions, despite being closest to patients and responsible for care delivery.
  • 02Primary care requires complex, nuanced decision-making but is often managed with productivity expectations designed for procedural specialties, pushing work home and some physicians toward breaking point.
  • 03AI's highest value is reducing administrative burden and documentation so physicians have more time with patients, not replacing clinical judgment or human relationships.

Sep 8, 2026

MRI segmentation models can now label 80 structures, but deployment is the hard part

MRI segmentation models can now label 80 structures. TotalSegmentator MRI is an nnU-Net model that provides rapid segmentation of all major organs across all MRI sequences, according to Radiology Business. For health systems, deployment is the hard part.

  • 01The spread between 0.97 Dice on lungs and 0.54 on portal and splenic veins in MRSegmentator is the real operational story: enterprises need confidence flags and escalation paths, not a single headline score.
  • 02Hospitals planning radiation oncology and neuro volumetry programs can treat segmentation speedups as capacity gains only if downstream steps, contour review, dose planning inputs, and reporting templates, are standardized.

Sep 8, 2026

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512